Center for Scientific Review; Notice of Closed Meetings, 19305-19306 [2025-07944]
Download as PDF
<![CDATA[
Federal Register / Vol. 90, No. 87 / Wednesday, May 7, 2025 / Notices
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: May 28, 2025.
Closed: 12:00 p.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Meeting Format: Virtual Meeting.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301 North
Stonestreet Avenue, Bethesda, MD 20892.
Contact Person: Susan R.B. Weiss, Ph.D.,
Director, Division of Extramural Research,
Office of the Director, National Institute on
Drug Abuse, NIH, Three White Flint North,
RM 09D08, 11601 Landsdown Street,
Bethesda, MD 20852, 301–443–6480, sweiss@
nida.nih.gov.
Contact Person: Gillian Acca, Ph.D., Health
Scientist Administrator, Division of
Extramural Research, Office of Extramural
Policy, National Institute on Drug Abuse,
NIH, Three White Flint North, RM 09C70,
11601 Landsdown Street, Bethesda, MD
20852, 301–827–5863, gillian.acca@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
Dated: May 2, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–07942 Filed 5–6–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSK9W7S144PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
16:14 May 06, 2025
Jkt 265001
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Clinical Neuroimmunology and Brain
Tumors Study Section.
Date: June 5–6, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Aleksey G. Kazantsev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
Bethesda, MD 20817, 301–435–1042,
aleksey.kazantsev@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BRAIN
Initiative: Preclinical Proof of Concept for
Novel Recording and Modulation
Technologies in the Human CNS.
Date: June 6, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lai Yee Leung, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1011D,
Bethesda, MD 20892, (301) 827–8106,
leungl2@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Pathophysiology of Eye Disease—1
Study Section.
Date: June 9–10, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Afia Sultana, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4189,
Bethesda, MD 20892, (301) 827–7083,
sultanaa@mail.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Clinical Management in General Care
Settings Study Section.
Date: June 9–10, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jessica Campbell
Chambers, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–5693,
jessica.chambers@nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
19305
Cardiovascular and Respiratory Diseases
Study Section.
Date: June 9–10, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Raquel L. Velazquezkronen, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Dr.,
Bethesda, MD 20892, (513) 301–9047,
velazquezrl@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Pathophysiology of Obesity and Metabolic
Disease Study Section.
Date: June 9–10, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Elaine Sierra-Rivera, Ph.D.,
IRG Chief, EMNR IRG, Center for Scientific
Review, National Institutes of Health, 6701
Rockledge Drive, Room 6182, MSC 7892,
Bethesda, MD 20892, (301) 435–2514,
riverase@csr.nih.gov.
Name of Committee: Brain Disorders and
Clinical Neuroscience Integrated Review
Group; Brain Injury and Neurovascular
Pathologies Study Section.
Date: June 9–10, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alexander Yakovlev,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206,
MSC 7846, Bethesda, MD 20892, 301–435–
1254, yakovleva@csr.nih.gov.
Name of Committee: Applied Immunology
and Disease Control Integrated Review
Group; Interspecies Microbial Interactions
and Infectious Study Section.
Date: June 9–10, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Address: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Irene Ramos lopez,
Scientific Review Officer, The Center for
Scientific Review, The National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4891, irene.ramoslopez@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
E:\FR\FM\07MYN1.SGM
07MYN1
19306
Federal Register / Vol. 90, No. 87 / Wednesday, May 7, 2025 / Notices
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 2, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2025–07944 Filed 5–6–25; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Office of the Secretary
[25XD4523WS; DS62200000;
DWSN00000.000000; DP.62206; OMB
Control Number 1090–0009]
Agency Information Collection
Activities; Donor Certification Form
Office of Financial
Management, Office of the Secretary,
Interior.
ACTION: Notice of information collection;
request for comment.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995, we,
the Office of Financial Management,
Office of the Secretary, Department of
the Interior, propose to renew an
information collection.
DATES: Interested persons are invited to
submit comments. To ensure your
comments are considered, we must
receive your comments on or before July
7, 2025.
ADDRESSES: Send your comments on
this information collection request (ICR)
by mail to Joshua Kamp, Office of
Financial Management, 1849 C St. NW,
MS 2557 MIB, Washington, DC 20240;
or by email to Joshua_Kamp@
ios.doi.gov. Please reference Office of
Management and Budget (OMB) Control
Number 1090–0009 in the subject line of
your comments.
FOR FURTHER INFORMATION CONTACT: To
request additional information about
this ICR, contact Joshua Kamp, Office of
Financial Management, 1849 C St. NW,
MS 2557 MIB, Washington, DC 20240;
or by email to Joshua_Kamp@ios.doi.gov
or by telephone at 202–208–4610.
Individuals in the United States who are
deaf, deafblind, hard of hearing, or have
a speech disability may dial 711 (TTY,
TDD, or TeleBraille) to access
telecommunications relay services.
Individuals outside the United States
should use the relay services offered
within their country to make
international calls to the point-ofcontact in the United States.
SUPPLEMENTARY INFORMATION: In
accordance with the Paperwork
khammond on DSK9W7S144PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:14 May 06, 2025
Jkt 265001
Reduction Act of 1995 (PRA), 44 U.S.C.
3501 et seq., and 5 CFR 1320.8(d)(1), all
information collections require prior
approval. We may not conduct or
sponsor and you are not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
As part of our continuing effort to
reduce paperwork and respondent
burdens, we invite the public and other
Federal agencies to comment on new,
proposed, revised, and continuing
collections of information. This helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand our
information collection requirements and
provide the requested data in the
desired format.
We are especially interested in public
comment addressing the following:
(1) Whether or not the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether or not the
information will have practical utility;
(2) The accuracy of our estimate of the
burden for this collection of
information, including the validity of
the methodology and assumptions used;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) How might the agency minimize
the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of response.
Comments that you submit in
response to this notice are a matter of
public record. We will include or
summarize each comment in our request
to OMB to approve this ICR. Before
including your address, phone number,
email address, or other personal
identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract: This notice identifies an
information collection that the Office of
Financial Management has submitted to
OMB for approval to allow the
Department and its bureaus and offices
to continue collecting information from
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
prospective donors relative to their
relationships with the Department. The
Department and its bureaus and offices
have gift acceptance authorities. In
support of its many donation authorities
and the increasing numbers of
donations, the Department’s policy is to
ask those proposing to donate gifts
valued at $25,000 or more to provide
information regarding their
relationships with the Department. This
policy ensures that the acceptance of a
gift does not create legal or ethical
issues for the donors and the
Department donees. A form is used to
collect information relevant to the
acceptability of the proposed donation
in conformance with the Department’s
donations policy. Prospective donors
complete the form, certify the
information on it, and submit the form
to the Department donee for review. The
donor’s certification of any interactions
with the Department gives the staff
vetting the proposed donation basic
information to be verified, resulting in
a more efficient and timely donation
review process.
Title of Collection: Donor Certification
Form.
OMB Control Number: 1090–0009.
Form Number: DI–3680.
Type of Review: Extension of a
currently approved collection.
Respondents/Affected Public:
Individuals/households, businesses,
not-for-profit institutions, Tribal
governments.
Total Estimated Number of Annual
Respondents: 250.
Total Estimated Number of Annual
Responses: 250.
Estimated Completion Time per
Response: 20 minutes.
Total Estimated Number of Annual
Burden Hours: 83 hours.
Respondent’s Obligation: Voluntary.
Frequency of Collection: Once per
prospective donor per fiscal year.
Total Estimated Annual Nonhour
Burden Cost: None.
An agency may not conduct or
sponsor and a person is not required to
respond to a collection of information
unless it displays a currently valid OMB
control number.
The authority for this action is the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
Tonya R. Johnson-Simmons,
Deputy Chief Financial Officer.
[FR Doc. 2025–07892 Filed 5–6–25; 8:45 am]
BILLING CODE 4334–32–P
E:\FR\FM\07MYN1.SGM
07MYN1
]]>Agencies
[Federal Register Volume 90, Number 87 (Wednesday, May 7, 2025)]
[Notices]
[Pages 19305-19306]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-07944]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Clinical Neuroimmunology and Brain Tumors
Study Section.
Date: June 5-6, 2025.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Aleksey G. Kazantsev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20817, 301-
435-1042, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; BRAIN Initiative: Preclinical Proof of Concept for Novel
Recording and Modulation Technologies in the Human CNS.
Date: June 6, 2025.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Lai Yee Leung, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1011D, Bethesda, MD 20892, (301) 827-8106,
[email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Pathophysiology of Eye Disease--1 Study
Section.
Date: June 9-10, 2025.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Afia Sultana, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4189, Bethesda, MD 20892, (301) 827-7083,
[email protected].
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group; Clinical Management in General Care
Settings Study Section.
Date: June 9-10, 2025.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Jessica Campbell Chambers, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-5693,
[email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cardiovascular and Respiratory Diseases
Study Section.
Date: June 9-10, 2025.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Raquel L. Velazquez-kronen, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Dr., Bethesda, MD 20892, (513) 301-9047,
[email protected].
Name of Committee: Endocrinology, Metabolism, Nutrition and
Reproductive Sciences Integrated Review Group; Pathophysiology of
Obesity and Metabolic Disease Study Section.
Date: June 9-10, 2025.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Elaine Sierra-Rivera, Ph.D., IRG Chief, EMNR
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 6182, MSC 7892, Bethesda, MD 20892, (301)
435-2514, [email protected].
Name of Committee: Brain Disorders and Clinical Neuroscience
Integrated Review Group; Brain Injury and Neurovascular Pathologies
Study Section.
Date: June 9-10, 2025.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Alexander Yakovlev, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5206, MSC 7846, Bethesda, MD
20892, 301-435-1254, [email protected].
Name of Committee: Applied Immunology and Disease Control
Integrated Review Group; Interspecies Microbial Interactions and
Infectious Study Section.
Date: June 9-10, 2025.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Address: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892.
Meeting Format: Virtual Meeting.
Contact Person: Irene Ramos lopez, Scientific Review Officer,
The Center for Scientific Review, The National Institutes of Health,
6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-4891,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844,
[[Page 19306]]
93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)
Dated: May 2, 2025.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-07944 Filed 5-6-25; 8:45 am]
BILLING CODE 4140-01-P
